Lorrain Daniel S. bought CTNM
January 30, 2026 · Form 4 insider transaction
Lorrain Daniel S. bought 160,000 shares of Contineum Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
160,000
Price
$0.00
Total value
N/A
InsiderLorrain Daniel S.
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateJanuary 30, 2026
Shares owned after160,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"). The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.